A research collaboration between Center for Healthy Aging at the University of Copenhagen with company specializing in artificial intelligence (AI) has been announced for developing a solutions for preventing early aging. Their main aim is to develop medicines for preventing and curing a broad range of diseases associated with aging like Alzheimer’s, Parkinson’s and cardiovascular diseases.This collaboration is to increase health span for everyone on the planet.
Researchers in the genetics of aging at the Department of Cellular and Molecular Medicine have partnered with the Baltimore-based company, Insilico Medicine that specializes in AI to find molecules which can be developed into drugs to cure and prevent the diseases. The main target is to find the molecules that repair DNA and prevent accelerated aging.
The Insilico Medicine are focusing on interventions in aging with AI. Many of these molecules aim to induce the expression of certain genes involved in the endogenous repair processes to slow down and even reverse some of the aging-associated diseases. By applying a specific branch of artificial intelligence called Deep Learning (DL) on multi-modal data, the company aims to discover molecules that can stimulate the repair of the DNA.
The research teams will be able to test the molecules identified using the artificial intelligence methods to select the most effective ones for joint development into novel medicines.
Insilico Medicine was the first company to apply deep generative adversarial networks (GANs) to generation of new molecular structures with specified parameters and published a seminal papers in Oncotarget and Molecular Pharmaceutics. Another paper published in Molecular Pharmaceutics in 2016, demonstrated the proof of concept of the application of deep neural networks for predicting the therapeutic class of the molecule using the transcriptional response data, received the American Chemical Society Editors’ Choice Award.
New molecules discovered by using the new generation of artificial intelligence will lead a huge benfit in pharmaceutical sector.
The orignal story was published in eurekaalert